Hong Kong poised for human trials of vaccine

No lasting yuan impact from US tech stock rout A nasal-spray Covid-19 vaccine, jointly developed by the University of Hong Kong and Xiamen University, will have phase-1 clinical trials in November in Hong Kong. About 100 volunteers will be recruited for trials of the vaccine, Yuen Kwok-yung, head of the Department of Microbiology at the University of Hong Kong, said Thursday. The Food and Health Bureau has granted a HK$20 million (US$2.58 million) to buy insurance for the participants, Yuen said. The phase-1 trials would be completed within two months. More than 10,000 people would take part in phase-2 and 3 trials. It would take at least a year for the vaccine to be launched for sale, he...